Cargando…

Potential utility of risk stratification for multicancer screening with liquid biopsy tests

Our proof-of-concept study reveals the potential of risk stratification by the combined effects of age, polygenic risk scores (PRS), and non-genetic risk factors in increasing the risk-benefit balance of rapidly emerging non-invasive multicancer early detection (MCED) liquid biopsy tests. We develop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Elle S., Scharpf, Robert B., Garcia-Closas, Montserrat, Visvanathan, Kala, Velculescu, Victor E., Chatterjee, Nilanjan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122653/ https://www.ncbi.nlm.nih.gov/pubmed/37087533 http://dx.doi.org/10.1038/s41698-023-00377-w

Ejemplares similares

Multicancer early detection tests: where are we?
por: Loomans-Kropp, Holli A
Publicado: (2022)

Assessing ZNF154 methylation in patient plasma as a multicancer marker in liquid biopsies from colon, liver, ovarian and pancreatic cancer patients
por: Miller, Brendan F., et al.
Publicado: (2021)

Evaluating Stacked Methylation Markers for Blood-Based Multicancer Detection
por: Funderburk, Karen, et al.
Publicado: (2023)

RAMRSGL: A Robust Adaptive Multinomial Regression Model for Multicancer Classification
por: Wang, Lei, et al.
Publicado: (2021)

Reply to: Limitations of molecular testing in combination with computerized tomographic for lung cancer screening
por: Mathios, Dimitrios, et al.
Publicado: (2022)

Dying To Find Out: The Cost of Time at the Dawn of the Multicancer Early Detection Era
por: Klein, Eric A., et al.
Publicado: (2023)

Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer
por: Semenkovich, Nicholas P., et al.
Publicado: (2023)

Identification of RET fusions in a Chinese multicancer retrospective analysis by next‐generation sequencing
por: Shi, Minke, et al.
Publicado: (2021)

Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk
por: Painter, Jodie N., et al.
Publicado: (2015)

Liquid biopsy epigenomic profiling for cancer subtyping
por: Baca, Sylvan C., et al.
Publicado: (2023)

UTILITY OF ICD-9 FOR INDIAN PATIENTS : AN OPINION SURVEY
por: Kala, A.K.
Publicado: (1985)

Oncosuppressor-Mutated Cells as a Liquid Biopsy Test for Cancer-Screening
por: Abdouh, Mohamed, et al.
Publicado: (2019)

The Promise of Multicancer Early Detection. Comment on Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm. Diagnostics 2021, 11, 2171
por: Klein, Eric A., et al.
Publicado: (2022)

Liquid biopsy: a new source of candidate biomarkers in amyotrophic lateral sclerosis
por: Mendioroz, Maite, et al.
Publicado: (2018)

Torque Teno Virus for Risk Stratification of Acute Biopsy-Proven Alloreactivity in Kidney Transplant Recipients
por: Strassl, Robert, et al.
Publicado: (2019)

Evolving Clinical Utility of Liquid Biopsy in Gastrointestinal Cancers
por: Jacobson, Richard A., et al.
Publicado: (2019)

Translational Utility of Liquid Biopsies in Thyroid Cancer Management
por: Wijewardene, Ayanthi A., et al.
Publicado: (2021)

Potential clinical utility of liquid biopsies in ovarian cancer
por: Zhu, Jie Wei, et al.
Publicado: (2022)

The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy
por: Song, Wan, et al.
Publicado: (2019)

Utilizing Social Media Advertisements and Participant Social Networks to Recruit African American Breast Cancer Survivors: Design and Rationale
por: Connor, Avonne E., et al.
Publicado: (2022)

Mutation-Agnostic Detection of Colorectal Cancer Using Liquid Biopsy-Based Methylation-Specific Signatures
por: Gouda, Mohamed A, et al.
Publicado: (2022)

Wasm-iCARE: a portable and privacy-preserving web module to build, validate, and apply absolute risk models
por: Balasubramanian, Jeya Balaji, et al.
Publicado: (2023)

Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases
por: McCabe, Mark J., et al.
Publicado: (2019)

Stratification of Oligometastatic Prostate Cancer Patients by Liquid Biopsy: Clinical Insights from a Pilot Study
por: Colosini, Antonella, et al.
Publicado: (2022)

Liquid biopsy genotyping in lung cancer: ready for clinical utility?
por: Huang, Wei-Lun, et al.
Publicado: (2017)

The Utility of Repetitive Cell-Free DNA in Cancer Liquid Biopsies
por: Gezer, Ugur, et al.
Publicado: (2022)

Potential utility of miRNAs for liquid biopsy in breast cancer
por: Liu, Xiangrong, et al.
Publicado: (2022)

Development of an Automated Liquid Biopsy Assay for Methylated Markers in Advanced Breast Cancer
por: Fackler, Mary Jo, et al.
Publicado: (2022)

Sex-Specific miRNA Differences in Liquid Biopsies from Subjects with Solid Tumors and Healthy Controls
por: Tomeva, Elena, et al.
Publicado: (2023)

Diagnostic performance of Idylla MSI test in colorectal cancer biopsies
por: Ukkola, Iiris, et al.
Publicado: (2023)

iCARE: An R package to build, validate and apply absolute risk models
por: Pal Choudhury, Parichoy, et al.
Publicado: (2020)

Clinically guided core biopsy and cutaneous punch biopsy in the evaluation of breast lesions: a necessary test or an obsolete skill?
por: Alameer, Aqeel, et al.
Publicado: (2022)

Clinical Utility of Liquid Biopsy-Based Actionable Mutations Detected via ddPCR
por: Palacín-Aliana, Irina, et al.
Publicado: (2021)

Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient’s Stratification
por: Ginghina, Octav, et al.
Publicado: (2022)

Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer
por: Moisoiu, Tudor, et al.
Publicado: (2022)

Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer
por: Semenkovich, Nicholas P., et al.
Publicado: (2023)

Targeting viral liquid–liquid phase separation
por: York, Ashley
Publicado: (2021)

Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?
por: Maas, Moritz, et al.
Publicado: (2021)

Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis
por: Matuszczak, Milena, et al.
Publicado: (2021)

Liquid Biopsy, an Everchanging Balance between Clinical Utility and Emerging Technologies
por: Cucciniello, Linda, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_trltdfg6h8pj4ekhvp7sup657t